Esoform has been acquired by Ecolab
The family owners of Esoform have sold the company to Ecolab for an undisclosed consideration.
Esoform is active in the study, development, production and commercialization of disinfectants, infection prevention and personal care solutions. The company is a leading player in the Italian hospital market with a presence in pharmacies and the mass market.
Ecolab, based in the US, is the global leader in water, hygiene and energy technologies and services that provide and protect clean water, safe food, abundant energy and healthy environments. With this transaction Ecolab plans to expand its healthcare business into Europe, using the Esoform manufacturing plant as the production hub for the region.
Oaklins' team in Italy advised Esoform on the exit strategy and conducted negotiations with potential buyers throughout the transaction. Through a series of bids, the team optimized their proceeds and obtained a remarkable multiple from Ecolab.
Talk to the deal team
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreSaideep Healthcare and Research has raised equity
Saideep Healthcare and Research Private Limited has successfully completed a fundraising. This funding will help Saideep become a leading healthcare brand, offering advanced specialties across the region. The funds from this collaboration will be used to diversify into new and complex specialties, expand infrastructure and meet the growing demand for high-quality healthcare services in Western India.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more